Literature DB >> 29968539

Drug Use is Associated with Anti-CD4 IgG-mediated CD4+ T Cell Death and Poor CD4+ T Cell Recovery in Viral-suppressive HIV-infected Individuals Under Antiretroviral Therapy.

Wei Jiang1,2, Zhenwu Luo1, Lisa Martin2, Zhuang Wan1, Pingfu Fu3, Amanda Wagner4, Binhua Ling5, Sonya L Heath6, Azizul Haque1, Aimee McRae-Clark4,7.   

Abstract

BACKGROUND: The role and mechanism of drug use or abuse in Antiretroviral Therapy (ART)-treated HIV disease are not completely known.
METHODS: To investigate the impact of drug use on HIV pathogenesis without confounding by HIV replication and ART adherence, we first analyzed the data from our clinical database in 103 HIV+ subjects with viral-suppressed ART treatment by a multiple regression test.
RESULTS: We found that HIV+ drug users had lower CD4+ T cell counts but higher CD8+ T cell counts compared to HIV+ non-drug users, and both drug use and nadir CD4+ T cell counts was independently associated with CD4+ T cell recovery after controlling for sex and age. Next, we enrolled individuals from four study groups, HIV-negative and HIV+ subjects without any substance use, HIV-negative and HIV+ subjects with current illicit drug use (either non-injection cocaine or cannabis). All HIV+ subjects were viral-suppressed with ART treatment (≥ 2 years). Notably, HIV+ drug users had increased plasma anti-CD4 IgG levels compared to the other three study groups which were inversely correlated with decreased CD4+ T cell counts only in HIV+ drug users. There was a significant increase in CD4+ T cell recovery following ART in HIV+ non-drug users but not in HIV+ drug users. Anti-CD4 IgGs purified from plasma of HIV+ drug users induced CD4+ T cell death in vitro through Antibody-Dependent Cytotoxicity (ADCC).
CONCLUSION: These results suggest that drug use prevents immune reconstitution in HIV-infected individuals despite long-term ART treatment and viral suppression. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  CD4+ T cell recovery; HIV; anti-CD4 IgG; antibody-dependent cytotoxicity; antiretroviral therapy; drug use.

Mesh:

Substances:

Year:  2018        PMID: 29968539      PMCID: PMC6115301          DOI: 10.2174/1570162X16666180703151208

Source DB:  PubMed          Journal:  Curr HIV Res        ISSN: 1570-162X            Impact factor:   1.581


  66 in total

1.  Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy.

Authors:  Gilbert R Kaufmann; Hansjakob Furrer; Bruno Ledergerber; Luc Perrin; Milos Opravil; Pietro Vernazza; Matthias Cavassini; Enos Bernasconi; Martin Rickenbach; Bernard Hirschel; Manuel Battegay
Journal:  Clin Infect Dis       Date:  2005-06-24       Impact factor: 9.079

2.  Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection.

Authors:  Gilad Doitsh; Nicole L K Galloway; Xin Geng; Zhiyuan Yang; Kathryn M Monroe; Orlando Zepeda; Peter W Hunt; Hiroyu Hatano; Stefanie Sowinski; Isa Muñoz-Arias; Warner C Greene
Journal:  Nature       Date:  2014-01-23       Impact factor: 49.962

3.  Cocaine-induced oxidative stress precedes cell death in human neuronal progenitor cells.

Authors:  H Fai Poon; Laila Abdullah; Myles A Mullan; Michael J Mullan; Fiona C Crawford
Journal:  Neurochem Int       Date:  2006-09-07       Impact factor: 3.921

4.  Cycling memory CD4+ T cells in HIV disease have a diverse T cell receptor repertoire and a phenotype consistent with bystander activation.

Authors:  Wei Jiang; Souheil-Antoine Younes; Nicholas T Funderburg; Joseph C Mudd; Enrique Espinosa; Miles P Davenport; Denise C Babineau; Scott F Sieg; Michael M Lederman
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

5.  HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS. Effect of neocortical involvement.

Authors:  J E Bell; R P Brettle; A Chiswick; P Simmonds
Journal:  Brain       Date:  1998-11       Impact factor: 13.501

6.  Methamphetamine use, sexual activity, patient-provider communication, and medication adherence among HIV-infected patients in care, San Francisco 2004-2006.

Authors:  Carina Marquez; Samuel J Mitchell; C Bradley Hare; Malcolm John; Jeffrey D Klausner
Journal:  AIDS Care       Date:  2009-05

7.  Risk of clinical progression among patients with immunological nonresponse despite virological suppression after combination antiretroviral treatment.

Authors:  Giuseppe Lapadula; Alessandro Cozzi-Lepri; Giulia Marchetti; Andrea Antinori; Alessandro Chiodera; Emanuele Nicastri; Giustino Parruti; Massimo Galli; Andrea Gori; Antonella d'Arminio Monforte
Journal:  AIDS       Date:  2013-03-13       Impact factor: 4.177

8.  Methamphetamine alters blood brain barrier permeability via the modulation of tight junction expression: Implication for HIV-1 neuropathogenesis in the context of drug abuse.

Authors:  Supriya D Mahajan; Ravikumar Aalinkeel; Donald E Sykes; Jessica L Reynolds; B Bindukumar; Adaffaras Adal; Mingshen Qi; Jennifer Toh; Gaixia Xu; Paras N Prasad; Stanley A Schwartz
Journal:  Brain Res       Date:  2008-02-13       Impact factor: 3.252

9.  HIV-1 Tat protein alter the tight junction integrity and function of retinal pigment epithelium: an in vitro study.

Authors:  Ling Bai; Zhenping Zhang; Hui Zhang; Xiumei Li; Qiurong Yu; Haotian Lin; Wenhui Yang
Journal:  BMC Infect Dis       Date:  2008-06-06       Impact factor: 3.090

10.  Impact of Age and Sex on CD4+ Cell Count Trajectories following Treatment Initiation: An Analysis of the Tanzanian HIV Treatment Database.

Authors:  Arianna R Means; Kathryn A Risher; Eva L Ujeneza; Innocent Maposa; Joseph Nondi; Steven E Bellan
Journal:  PLoS One       Date:  2016-10-07       Impact factor: 3.240

View more
  2 in total

1.  A link between IL-23 and anti-CD4 autoantibody production in antiretroviral-treated HIV-infected individuals.

Authors:  Zhenwu Luo; Min Li; Fuli Mi; Zhefeng Meng; Guoqiang Du; Lisa Martin; Hui Liu; Ping Jin; David Stroncek; Sonya L Heath; Wei Jiang
Journal:  J Virol       Date:  2021-03-17       Impact factor: 5.103

2.  Elevated Cerebrospinal Fluid Anti-CD4 Autoantibody Levels in HIV Associate with Neuroinflammation.

Authors:  Da Cheng; Zhenwu Luo; Xiaoyu Fu; Sophie Stephenson; Clara Di Germanio; Philip J Norris; Dietmar Fuchs; Lishomwa C Ndhlovu; Quan-Zhen Li; Henrik Zetterberg; Magnus Gisslen; Richard W Price; Shifang Peng; Wei Jiang
Journal:  Microbiol Spectr       Date:  2022-01-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.